Serum levels and significance of soluble B-cell maturation antigen in childhood-onset systemic lupus erythematosus with renal involvement
Sign Up to like & getrecommendations! Published in 2023 at "Lupus"
DOI: 10.1177/09612033231164633
Abstract: Objective The aim of this study was to investigate serum levels of soluble B-cell maturation antigen (sBCMA) in childhood-onset systemic lupus erythematous (cSLE) patients with renal involvement, and to elucidate their association with clinical characteristics.… read more here.
Keywords: sbcma levels; serum sbcma; renal involvement; csle patients ... See more keywords
Correlation between the expression of soluble BCMA and short-term/long-term curative effect and survival outcomes of anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma
Sign Up to like & getrecommendations! Published in 2025 at "Cell Transplantation"
DOI: 10.1177/09636897251374203
Abstract: This study aimed to investigate whether soluble B-cell maturation antigen (sBCMA) levels could be predictive biomarker for short-term and long-term therapeutic efficacy and survival outcomes following anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma (R/R… read more here.
Keywords: sbcma levels; term; long term; car ... See more keywords
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007625
Abstract: B-cell maturation antigen (BCMA) is selectively expressed as a surface protein on plasma cells and is a validated target for multiple myeloma (MM). A soluble form of BCMA (sBCMA) is elevated in the sera of… read more here.
Keywords: sbcma levels; sbcma; bcma; talquetamab ... See more keywords